Xu YZ - Search Results

1

Matricellular proteins: From cardiac homeostasis to immune regulation.

Meng L, Chen HM, Zhang JS, Wu YR, Xu YZ. Meng L, et al. Among authors: xu yz. Biomed Pharmacother. 2024 Nov;180:117463. doi: 10.1016/j.biopha.2024.117463. Epub 2024 Sep 20. Biomed Pharmacother. 2024. PMID: 39305814 Free article. Review.

2

RNA modifications in cardiovascular diseases, the potential therapeutic targets.

Wu Y, Zhan S, Xu Y, Gao X. Wu Y, et al. Life Sci. 2021 Aug 1;278:119565. doi: 10.1016/j.lfs.2021.119565. Epub 2021 May 6. Life Sci. 2021. PMID: 33965380 Review.

3

Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway.

Xu L, He D, Wu Y, Shen L, Wang Y, Xu Y. Xu L, et al. Phytomedicine. 2022 Dec;107:154471. doi: 10.1016/j.phymed.2022.154471. Epub 2022 Sep 21. Phytomedicine. 2022. PMID: 36182795

4

TNFSF14/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3Kγ/SGK1 pathway-dependent M2 macrophage polarisation.

Wu Y, Zhan S, Chen L, Sun M, Li M, Mou X, Zhang Z, Xu L, Xu Y. Wu Y, et al. J Transl Med. 2023 Aug 14;21(1):544. doi: 10.1186/s12967-023-04381-3. J Transl Med. 2023. PMID: 37580750 Free PMC article.

5

A Microenvironment-responsive small-molecule probe and application in quick acute myocardial infarction imaging.

Lu J, Wu Y, Zhan S, Zhong Y, Guo Y, Gao J, Zhang B, Dong X, Che J, Xu Y. Lu J, et al. Talanta. 2024 Apr 1;270:125571. doi: 10.1016/j.talanta.2023.125571. Epub 2023 Dec 22. Talanta. 2024. PMID: 38154354

6

Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells.

Xu L, Jiang Y, Bi Y, Zheng S, Wu Y, Wu Y, Xu Y, Chen J. Xu L, et al. Biomed Pharmacother. 2024 Jun;175:116684. doi: 10.1016/j.biopha.2024.116684. Epub 2024 May 6. Biomed Pharmacother. 2024. PMID: 38713951 Free article.

7

The investigation of potential mechanism of Fuzhengkangfu Decoction against Diabetic myocardial injury based on a combined strategy of network pharmacology, transcriptomics, and experimental verification.

Li M, Chen L, Liu X, Wu Y, Chen X, Chen H, Zhong Y, Xu Y. Li M, et al. Biomed Pharmacother. 2024 Aug;177:117048. doi: 10.1016/j.biopha.2024.117048. Epub 2024 Jul 2. Biomed Pharmacother. 2024. PMID: 38959606 Free article.

8

Pharmacological therapy targeting the immune response in atherosclerosis.

Wu Y, Xu Y, Xu L. Wu Y, et al. Int Immunopharmacol. 2024 Nov 15;141:112974. doi: 10.1016/j.intimp.2024.112974. Epub 2024 Aug 21. Int Immunopharmacol. 2024. PMID: 39168023 Review.

9

Drug therapy for myocarditis induced by immune checkpoint inhibitors.

Wu Y, Xu Y, Xu L. Wu Y, et al. Front Pharmacol. 2023 May 25;14:1161243. doi: 10.3389/fphar.2023.1161243. eCollection 2023. Front Pharmacol. 2023. PMID: 37305530 Free PMC article. Review.

10

Impact of periprocedural myocardial injury on long-term clinical outcomes of chronic total occlusion patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.

Liu MJ, Chen CF, Gao XF, Liu XH, Xu YZ. Liu MJ, et al. Among authors: xu yz. Coron Artery Dis. 2020 May;31(3):208-214. doi: 10.1097/MCA.0000000000000813. Coron Artery Dis. 2020. PMID: 31703014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters